Cargando…

Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus

INTRODUCTION: Considerable confusions on treatment target have resulted from recent changes in guidelines. Evidence in medical guidelines came from clinical trials with highly selected patients, whereas treatment goals may differ in some subgroups. This study aimed to assess optimal treatment goals...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Qian, Lin, Yilu, Fonseca, Vivian A, Shi, Lizheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532550/
https://www.ncbi.nlm.nih.gov/pubmed/34675042
http://dx.doi.org/10.1136/bmjdrc-2021-002396
_version_ 1784587092734509056
author Shi, Qian
Lin, Yilu
Fonseca, Vivian A
Shi, Lizheng
author_facet Shi, Qian
Lin, Yilu
Fonseca, Vivian A
Shi, Lizheng
author_sort Shi, Qian
collection PubMed
description INTRODUCTION: Considerable confusions on treatment target have resulted from recent changes in guidelines. Evidence in medical guidelines came from clinical trials with highly selected patients, whereas treatment goals may differ in some subgroups. This study aimed to assess optimal treatment goals (A1C, blood pressure, low-density lipoprotein cholesterol (LDL-C)) for patients with type 2 diabetes mellitus (T2DM), which lead to optimal health outcomes by different treatment strategies. RESEARCH DESIGN AND METHODS: A retrospective longitudinal study was conducted for veterans with T2DM by using US Veterans Affairs Administrative Database (2005−2015). Medical records were prepared for repeated evaluation performed at 6-month intervals and multivariate longitudinal regression was used to estimate the risk of microvascular and macrovascular complication events. Second-degree polynomial and splines were applied to identify the optimal goals in their associations with lowest risk of clinical outcomes, controlling for demographic characteristics, medical history, and medications. RESULTS: A total of 124 651 patients with T2DM were selected, with mean of 6.72 follow-up years. In the general population, to achieve the lowest risk of microvascular and macrovascular complication, the optimal goals were A1C=6.81%, LDL-C=109.10 mg/dL; and A1C=6.76%, LDL-C=111.65 mg/dL, systolic blood pressure (SBP)=130.60 mmHg, respectively. The optimal goals differed between age and racial subgroups. Lower SBP for younger patients and lower LDL-C for black patients were associated with better health outcomes. CONCLUSIONS: Optimal treatment goals were identified and multi-faceted treatment strategies targeting hyperglycemia and hyperlipidemia and hypertension may improve health outcome in veterans with T2DM. In addition to guidelines’ recommended goals, health systems may examine their own large diverse patients with T2DM for better quality of care.
format Online
Article
Text
id pubmed-8532550
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85325502021-11-04 Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus Shi, Qian Lin, Yilu Fonseca, Vivian A Shi, Lizheng BMJ Open Diabetes Res Care Epidemiology/Health services research INTRODUCTION: Considerable confusions on treatment target have resulted from recent changes in guidelines. Evidence in medical guidelines came from clinical trials with highly selected patients, whereas treatment goals may differ in some subgroups. This study aimed to assess optimal treatment goals (A1C, blood pressure, low-density lipoprotein cholesterol (LDL-C)) for patients with type 2 diabetes mellitus (T2DM), which lead to optimal health outcomes by different treatment strategies. RESEARCH DESIGN AND METHODS: A retrospective longitudinal study was conducted for veterans with T2DM by using US Veterans Affairs Administrative Database (2005−2015). Medical records were prepared for repeated evaluation performed at 6-month intervals and multivariate longitudinal regression was used to estimate the risk of microvascular and macrovascular complication events. Second-degree polynomial and splines were applied to identify the optimal goals in their associations with lowest risk of clinical outcomes, controlling for demographic characteristics, medical history, and medications. RESULTS: A total of 124 651 patients with T2DM were selected, with mean of 6.72 follow-up years. In the general population, to achieve the lowest risk of microvascular and macrovascular complication, the optimal goals were A1C=6.81%, LDL-C=109.10 mg/dL; and A1C=6.76%, LDL-C=111.65 mg/dL, systolic blood pressure (SBP)=130.60 mmHg, respectively. The optimal goals differed between age and racial subgroups. Lower SBP for younger patients and lower LDL-C for black patients were associated with better health outcomes. CONCLUSIONS: Optimal treatment goals were identified and multi-faceted treatment strategies targeting hyperglycemia and hyperlipidemia and hypertension may improve health outcome in veterans with T2DM. In addition to guidelines’ recommended goals, health systems may examine their own large diverse patients with T2DM for better quality of care. BMJ Publishing Group 2021-10-21 /pmc/articles/PMC8532550/ /pubmed/34675042 http://dx.doi.org/10.1136/bmjdrc-2021-002396 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology/Health services research
Shi, Qian
Lin, Yilu
Fonseca, Vivian A
Shi, Lizheng
Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
title Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
title_full Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
title_fullStr Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
title_full_unstemmed Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
title_short Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
title_sort optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
topic Epidemiology/Health services research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532550/
https://www.ncbi.nlm.nih.gov/pubmed/34675042
http://dx.doi.org/10.1136/bmjdrc-2021-002396
work_keys_str_mv AT shiqian optimizingtreatmentgoalsforlongtermhealthoutcomesamongpatientswithtype2diabetesmellitus
AT linyilu optimizingtreatmentgoalsforlongtermhealthoutcomesamongpatientswithtype2diabetesmellitus
AT fonsecaviviana optimizingtreatmentgoalsforlongtermhealthoutcomesamongpatientswithtype2diabetesmellitus
AT shilizheng optimizingtreatmentgoalsforlongtermhealthoutcomesamongpatientswithtype2diabetesmellitus